Keyword Index

A

  • Access Profits First, Health Second: The Pharmaceutical Industry and the Global South; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Access to Medicines Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Action Research Helping Healthcare to Help Itself: A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Action Research Building Cross-sectoral Collaborations to Address Perinatal Health Inequities: Insights From the Dutch Healthy Pregnancy 4 All-3 Program [Volume 13, Issue 1, 2024, Pages 1-12]
  • Acute Care Innovative Models of Care for Hospitals of the Future [Volume 13, Issue 1, 2024, Pages 1-4]
  • Adaptability Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions [Volume 13, Issue 1, 2024, Pages 1-9]
  • Administrative Data Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea [Volume 13, Issue 1, 2024, Pages 1-9]
  • Advance Practice Nursing Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems [Volume 13, Issue 1, 2024, Pages 1-11]
  • Advantages Coopetition Strategy in the Healthcare: Good or Bad? [Volume 13, Issue 1, 2024, Pages 1-3]
  • Advocacy Practices of Trans-National Corporations: The Need to Change Global Economic and Political Norms; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Africa Why Are African Researchers Left Behind in Global Scientific Publications? – A Viewpoint [Volume 13, Issue 1, 2024, Pages 1-4]
  • Africa Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda [Volume 13, Issue 1, 2024, Pages 1-14]
  • Africa Identifying Positive Practices to Institutionalize Social Innovation in the Malawian Health System [Volume 13, Issue 1, 2024, Pages 1-11]
  • African Medicines Agency Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment [Volume 13, Issue 1, 2024, Pages 1-11]
  • Aging Negative Emotions Are Associated With Older Self-perceived Age: A Cross-section Study From the UK Biobank [Volume 13, Issue 1, 2024, Pages 1-8]
  • Aisa  Discrepancies Among Hospitals and Regions in the Provision of Low-Value Care [Volume 13, Issue 1, 2024, Pages 1-10]
  • Alcohol The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign [Volume 13, Issue 1, 2024, Pages 1-9]
  • Alcohol Industry  Policy Actors’ Perceptions of Conflicts of Interest and Alcohol Industry Engagement in UK Policy Processes [Volume 13, Issue 1, 2024, Pages 1-11]
  • Alcohol Policy Policy Actors’ Perceptions of Conflicts of Interest and Alcohol Industry Engagement in UK Policy Processes [Volume 13, Issue 1, 2024, Pages 1-11]
  • Algorithms Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Anthelmintic Drugs Entry of Migrant Workers to Malaysia: Consideration to Implement Mass Drug Administration Against Intestinal Parasitic Infections [Volume 13, Issue 1, 2024, Pages 1-5]
  • Anti-Vascular Endothelial Growth Factor Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis [Volume 13, Issue 1, 2024, Pages 1-10]
  • Anticancer Drugs Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China [Volume 13, Issue 1, 2024, Pages 1-10]
  • Article 5.3 Tobacco Industry Engagement in the House of Commons Science and Technology Select Committee E-Cigarettes Inquiry [Volume 13, Issue 1, 2024, Pages 1-10]
  • Article Processing Charges Why Are African Researchers Left Behind in Global Scientific Publications? – A Viewpoint [Volume 13, Issue 1, 2024, Pages 1-4]
  • Artificial Intelligence Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Asia Health Insurance Schemes and Their Influences on Healthcare Variation in Asian Countries: A Realist Review and Theory’s Testing in Thailand [Volume 13, Issue 1, 2024, Pages 1-18]
  • Australia Inhibitors and Supporters of Policy Change in the Regulation of Unhealthy Food Marketing in Australia [Volume 13, Issue 1, 2024, Pages 1-9]
  • Australia What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers [Volume 13, Issue 1, 2024, Pages 1-10]

B

  • Balance Energy Is Power; Comment on “Energy as a Social and Commercial Determinant of Health: A Qualitative Study of Australian Policy” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Behavioral Beliefs How Do the Determinants of Collaborative Consumption Influence Its Use in Healthcare? A Managerial Perspective [Volume 13, Issue 1, 2024, Pages 1-16]
  • Benefit Package The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-8]
  • Benefit Package Costing Interventions for Developing an Essential Package of Health Services: Application of a Rapid Method and Results From Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-17]
  • Birth Prevalence Spatial Distribution and Birth Prevalence of Congenital Heart Disease in Iran: A Systematic Review and Hierarchical Bayesian Meta-analysis [Volume 13, Issue 1, 2024, Pages 1-11]
  • Bottom-Up Innovation Employee-Driven Innovation as an Approach to Health System Strengthening in LMICs; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Burnout System-Based Interventions to Address Physician Burnout: A Qualitative Study of Canadian Family Physicians’ Experiences During the COVID-19 Pandemic [Volume 13, Issue 1, 2024, Pages 1-9]

C

  • CAR-T A New Outcomes-Based Payment Plan From a Chinese Company to Improve Patient Affordability of CAR-T Product [Volume 13, Issue 1, 2024, Pages 1-3]
  • CMO Configurations Required Capabilities for Employee-Driven Innovation to Emerge in Healthcare Organizations; Comment on “Employee-Driven Innovation in Health Organizations: Insights from a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-5]
  • COVAX Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • COVID-19 Forecasting the Early Impact of COVID-19 on Physician Supply in EU Countries [Volume 13, Issue 1, 2024, Pages 1-11]
  • COVID-19 Equity Lens on Canada’s COVID-19 Response: Review of the Literature [Volume 13, Issue 1, 2024, Pages 1-9]
  • COVID-19 What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers [Volume 13, Issue 1, 2024, Pages 1-10]
  • COVID-19 Analysis of the Prognosis Outcomes and Treatment Delay Among ST-Segment Elevation Myocardial Infarction Patients in Emergency Department Based on the Presence of Symptoms Suggestive of COVID-19 [Volume 13, Issue 1, 2024, Pages 1-8]
  • COVID-19 System-Based Interventions to Address Physician Burnout: A Qualitative Study of Canadian Family Physicians’ Experiences During the COVID-19 Pandemic [Volume 13, Issue 1, 2024, Pages 1-9]
  • COVID-19 The Adaptation of Digital Health Solutions During the COVID-19 Pandemic in Hungary: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • COVID-19 Resilience: Now What?; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-3]
  • COVID-19 Essential Factors on Effective Response at the Onset of the COVID-19 Pandemic; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • COVID-19 A Multifaceted Approach to Health Crisis in the Philippines; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-3]
  • COVID-19 Learning Health Systems Are Resilient Health Systems Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • COVID-19 Health and Social Care Inequalities During the First Wave of COVID-19 in Italy; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • COVID-19 Vaccines Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • COVID-19 vaccine Hoarding Vaccines or Hedging Vaccine R&D Risks? — Motivation for Overbooking COVID-19 Vaccines in High-Income Countries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Canada Equity Lens on Canada’s COVID-19 Response: Review of the Literature [Volume 13, Issue 1, 2024, Pages 1-9]
  • Canada System-Based Interventions to Address Physician Burnout: A Qualitative Study of Canadian Family Physicians’ Experiences During the COVID-19 Pandemic [Volume 13, Issue 1, 2024, Pages 1-9]
  • Canadian Institutes of Health Research Fostering Experiential Learning and Evidence-Informed Impact in Health Systems: Reflections From a Canadian Health System Impact Fellow [Volume 13, Issue 1, 2024, Pages 1-6]
  • Cancer Drug Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand [Volume 13, Issue 1, 2024, Pages 1-15]
  • Cancer Registry An Exploration of the Utility and Impacts of Implementation Science Strategies by Cancer Registries for Healthcare Improvement: A Systematic Review [Volume 13, Issue 1, 2024, Pages 1-12]
  • Capabilities Required Capabilities for Employee-Driven Innovation to Emerge in Healthcare Organizations; Comment on “Employee-Driven Innovation in Health Organizations: Insights from a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Change Mechanisms Activating Mechanisms Through Employee-Driven Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Childhood Obesity Retailer Responses to Public Consultations on the Adoption of Takeaway Management Zones Around Schools: A Longitudinal Qualitative Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • China Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-5]
  • China How Does Management Matter for Hospital Performance? Evidence From the Global Hospital Management Survey in China [Volume 13, Issue 1, 2024, Pages 1-9]
  • China Impact of the Diagnosis-Intervention Packet Payment Reform on Provider Behavior in China: A Controlled Interrupted Time Series Study [Volume 13, Issue 1, 2024, Pages 1-10]
  • China  Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China [Volume 13, Issue 1, 2024, Pages 1-10]
  • Clinical Decision Support Systems Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Clinical Governance Next Steps for Medical Specialist Enterprises in the Netherlands: Building Strong Clinical Governance and Leadership; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Clinical Outcomes How Does Management Matter for Hospital Performance? Evidence From the Global Hospital Management Survey in China [Volume 13, Issue 1, 2024, Pages 1-9]
  • Clinical Pathways The Economic Rationale for Healthcare Reform [Volume 13, Issue 1, 2024, Pages 1-3]
  • Clinical Value Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China [Volume 13, Issue 1, 2024, Pages 1-10]
  • Clinicaltrials.Gov Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials [Volume 13, Issue 1, 2024, Pages 1-6]
  • Co-Design Balancing Power and Co-production; Comment on “Research Co-production: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Co-production A Co-production Values and Principles Compass to Guide Along the Underused Pathway; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Codesign Research Coproduction: How Can Coproduction Teams Increase Traffic on the Pathway to Impact?; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Codex Understanding the Politics of Food Regulation and Public Health: An Analysis of Codex Standard-Setting Processes on Food Labelling [Volume 13, Issue 1, 2024, Pages 1-18]
  • Collaboration Why Systems Thinking is Needed to Center Trust in Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Collaboration  Intersectoral Partnerships Between Local Governments and Health Organisations in High-Income Contexts: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Collaborative Consumption How Do the Determinants of Collaborative Consumption Influence Its Use in Healthcare? A Managerial Perspective [Volume 13, Issue 1, 2024, Pages 1-16]
  • Collaborative Research Research Coproduction: How Can Coproduction Teams Increase Traffic on the Pathway to Impact?; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Coloniality Countering Coloniality in Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Commercial Determinants Practices of Trans-National Corporations: The Need to Change Global Economic and Political Norms; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Commercial Determinants Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures [Volume 13, Issue 1, 2024, Pages 1-14]
  • Commercial Determinants The Role of Social Movements in Reducing Harmful Corporate Practices; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Commercial Determinants Political Considerations When Monitoring the Commercial Determinants of Health; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Commercial Determinants of Health Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-17]
  • Commercial Determinants of Health The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign [Volume 13, Issue 1, 2024, Pages 1-9]
  • Commercial Determinants of Health Retailer Responses to Public Consultations on the Adoption of Takeaway Management Zones Around Schools: A Longitudinal Qualitative Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Commercial Determinants of Health How Could We Establish Monitoring and Surveillance of Health-Harming Corporations and Can Governments Be Trusted to Do It?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Commercial Determinants of Health  Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-20]
  • Community Learning From Countries on Measuring and Defining Community-Based Resilience in Health Systems: Voices From Nepal, Sierra Leone, Liberia, and Ethiopia [Volume 13, Issue 1, 2024, Pages 1-12]
  • Community Engagement Standing on the Shoulder of Power, Representation and Relational Trust; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Community participation What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers [Volume 13, Issue 1, 2024, Pages 1-10]
  • Community  Empowerment of Lay Mental Health Workers and Junior Psychologists Online in a Task-Shared, Rural Setting in Kerala, India [Volume 13, Issue 1, 2024, Pages 1-11]
  • Completed Trials  Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials [Volume 13, Issue 1, 2024, Pages 1-6]
  • Complex Adaptive Systems Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-17]
  • Complex Problem Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-20]
  • Complexity Why Systems Thinking is Needed to Center Trust in Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Compliance Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea [Volume 13, Issue 1, 2024, Pages 1-9]
  • Conflict of Interest “Caught in Each Other’s Traps”: Factors Perpetuating Incentive-Linked Prescribing Deals Between Physicians and the Pharmaceutical Industry [Volume 13, Issue 1, 2024, Pages 1-11]
  • Conflicts of Interest Policy Actors’ Perceptions of Conflicts of Interest and Alcohol Industry Engagement in UK Policy Processes [Volume 13, Issue 1, 2024, Pages 1-11]
  • Conflicts of Interest Understanding the Politics of Food Regulation and Public Health: An Analysis of Codex Standard-Setting Processes on Food Labelling [Volume 13, Issue 1, 2024, Pages 1-18]
  • Congenital Heart Disease Spatial Distribution and Birth Prevalence of Congenital Heart Disease in Iran: A Systematic Review and Hierarchical Bayesian Meta-analysis [Volume 13, Issue 1, 2024, Pages 1-11]
  • Consensus Methods Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Construct Clarity Construct Clarity in Physician-Hospital Alignment: The Need for Precision in Definition, Measurement, and Management; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Context Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors [Volume 13, Issue 1, 2024, Pages 1-11]
  • Contextual Factors Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors [Volume 13, Issue 1, 2024, Pages 1-11]
  • Continuing Education Continuing Education in Digital Skills for Healthcare Professionals — Mapping of the Current Situation in EU Member States [Volume 13, Issue 1, 2024, Pages 1-7]
  • Control Beliefs How Do the Determinants of Collaborative Consumption Influence Its Use in Healthcare? A Managerial Perspective [Volume 13, Issue 1, 2024, Pages 1-16]
  • Coopetition Strategy Coopetition Strategy in the Healthcare: Good or Bad? [Volume 13, Issue 1, 2024, Pages 1-3]
  • Coproduction Research Coproduction: How Can Coproduction Teams Increase Traffic on the Pathway to Impact?; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Coproduction Experiences of Research Coproduction in Uganda; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Corporate Political Activity Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures [Volume 13, Issue 1, 2024, Pages 1-14]
  • Corporate Political Activity Political Considerations When Monitoring the Commercial Determinants of Health; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Corporate Practices The Role of Social Movements in Reducing Harmful Corporate Practices; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Cost-Effectiveness Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan’s Essential Package of Health Services [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-9]
  • Cost-Effectiveness The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-12]
  • Cost-Effectiveness Economic Evaluation of Multilayer Silicone-Adhesive Polyurethane Foam Dressing for the Prevention of Pressure Ulcers in At-Risk Hospitalized Patients: US and Italian Perspective [Volume 13, Issue 1, 2024, Pages 1-8]
  • Costing Costing Interventions for Developing an Essential Package of Health Services: Application of a Rapid Method and Results From Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-17]
  • Cross-Sectoral Collaborations Building Cross-sectoral Collaborations to Address Perinatal Health Inequities: Insights From the Dutch Healthy Pregnancy 4 All-3 Program [Volume 13, Issue 1, 2024, Pages 1-12]

D

  • DCP3 Addressing the UHC Challenge Using the Disease Control Priorities 3 Approach: Lessons Learned and an Overview of the Pakistan Experience [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-10]
  • Data Attention to the Registry of Neglected Diseases: Idiopathic Granulomatous Mastitis as an Example [Volume 13, Issue 1, 2024, Pages 1-2]
  • Decentralisation Decentralisation of the Health System Derailed by Organisational Inertia in Machinga, Malawi [Volume 13, Issue 1, 2024, Pages 1-11]
  • Decision Criteria  The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-12]
  • Decision-Making Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors [Volume 13, Issue 1, 2024, Pages 1-11]
  • Decolonisation Balancing Power and Co-production; Comment on “Research Co-production: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Decolonization The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point [Volume 13, Issue 1, 2024, Pages 1-3]
  • Decolonization Countering Coloniality in Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Decolonization Centering Local Knowledge to Address the Imbrication of Settler Colonialism and Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Dedicated Fund Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand [Volume 13, Issue 1, 2024, Pages 1-15]
  • Degrowth Well-Being Economics – From Slogan to Discipline?; Comment on “Can a Well-Being Economy Save Us?” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Deliberative Dialogue Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Deliberative Dialogue Standing on the Shoulder of Power, Representation and Relational Trust; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Deliberative Processes Moving Towards Effective and Efficient Implementation of Evidence-Informed Deliberative Processes for Health Benefit Package Design: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Delivery of Healthcare Value-Based Integrated Care: A Systematic Literature Review [Volume 13, Issue 1, 2024, Pages 1-17]
  • Diabetes Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-5]
  • Diabetic Macular Edema Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis [Volume 13, Issue 1, 2024, Pages 1-10]
  • Diagnosis-Intervention Packet Impact of the Diagnosis-Intervention Packet Payment Reform on Provider Behavior in China: A Controlled Interrupted Time Series Study [Volume 13, Issue 1, 2024, Pages 1-10]
  • Diagnostic Errors Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens [Volume 13, Issue 1, 2024, Pages 1-12]
  • Diffusion All Hands on Deck. Transforming the Health System Requires Innovation, Through Individual- and Diffusion Efforts; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Diffusion of Innovations Life After the HSIF: Lessons From Diffusion of Innovation for Sustaining the Impact of Embeddedness; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Digital Health The Adaptation of Digital Health Solutions During the COVID-19 Pandemic in Hungary: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Digital Health To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practiceand Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue [Volume 13, Issue 1, 2024, Pages 1-14]
  • Digital Health Literacy How Do the Determinants of Collaborative Consumption Influence Its Use in Healthcare? A Managerial Perspective [Volume 13, Issue 1, 2024, Pages 1-16]
  • Digitalisation  All Hands on Deck. Transforming the Health System Requires Innovation, Through Individual- and Diffusion Efforts; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Diplomacy Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Disability Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda [Volume 13, Issue 1, 2024, Pages 1-14]
  • Disadvantages Coopetition Strategy in the Healthcare: Good or Bad? [Volume 13, Issue 1, 2024, Pages 1-3]
  • Discharged Patients The Effect of Integrated Care After Discharge From Hospitals on Outcomes Among Korean Older Adults [Volume 13, Issue 1, 2024, Pages 1-8]
  • Discrete Choice Experiment Public Heterogeneous Preferences for Low-Dose Computed Tomography Lung Cancer Screening Service Delivery in Western China: A Discrete Choice Experiment [Volume 13, Issue 1, 2024, Pages 1-11]
  • Discrete Choice Model Chinese Physicians’ Preference for Prescribing Brand-Name vs. Generic: A Discrete Choice Experimen [Volume 13, Issue 1, 2024, Pages 1-9]
  • Discrete-Choice Experiments Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada [Volume 13, Issue 1, 2024, Pages 1-12]
  • Disease Control Priorities Pakistan’s Progress on Universal Health Coverage: Lessons Learned in Priority Setting and Challenges Ahead in Reinforcing Primary Healthcare [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-5]
  • District Health System  The Meso-Level in Quality Improvement: Perspectives From a Maternal-Neonatal Health Partnership in South Africa [Volume 13, Issue 1, 2024, Pages 1-9]

E

  • E-Cigarettes Tobacco Industry Engagement in the House of Commons Science and Technology Select Committee E-Cigarettes Inquiry [Volume 13, Issue 1, 2024, Pages 1-10]
  • EAC Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment [Volume 13, Issue 1, 2024, Pages 1-11]
  • ECOWAS  Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment [Volume 13, Issue 1, 2024, Pages 1-11]
  • EHR The Adaptation of Digital Health Solutions During the COVID-19 Pandemic in Hungary: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • EPHS  Pakistan’s Progress on Universal Health Coverage: Lessons Learned in Priority Setting and Challenges Ahead in Reinforcing Primary Healthcare [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-5]
  • EQ-5D The Economic Rationale for Healthcare Reform [Volume 13, Issue 1, 2024, Pages 1-3]
  • Ecological Economics Well-Being Economics – From Slogan to Discipline?; Comment on “Can a Well-Being Economy Save Us?” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Economic Evaluation Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions [Volume 13, Issue 1, 2024, Pages 1-9]
  • Economic Evaluation Economic Evaluation of Multilayer Silicone-Adhesive Polyurethane Foam Dressing for the Prevention of Pressure Ulcers in At-Risk Hospitalized Patients: US and Italian Perspective [Volume 13, Issue 1, 2024, Pages 1-8]
  • Economic Extractivism Confronting the Colonial Roots of Global Health Inequities in Gaza; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Effects Evaluation  Value-Based Integrated Care: A Systematic Literature Review [Volume 13, Issue 1, 2024, Pages 1-17]
  • Efficiency Technical Efficiency of Prevention Services for Functional Dependency in Japan’s Public Long-term Care Insurance System: An Ecological Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Embedded Research Strengthening the Workforce for Equity-Centered Learning Health Systems: Reflections on Embedded Research and Research Generalism; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Embedded Research Fostering Experiential Learning and Evidence-Informed Impact in Health Systems: Reflections From a Canadian Health System Impact Fellow [Volume 13, Issue 1, 2024, Pages 1-6]
  • Embedded Research Training an Embedded Workforce to Realize Health System Impacts and the Promise of Learning Health Systems; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Embedded Research Reflections on the Health System Impact Fellowship and the Future of Embedded Research; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Embedded Research Training Reflections on the Health System Impact Fellowship and the Future of Embedded Research; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Embedded Researchers Training it Forward: The Role of Embedded Research Fellows in the Network of Scholars Program in Nova Scotia; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Embedded Science Life After the HSIF: Lessons From Diffusion of Innovation for Sustaining the Impact of Embeddedness; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Emergence Why Systems Thinking is Needed to Center Trust in Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Emergency Department Effect of the Presence of Emergency Departments With 300 or More Hospital Beds in Health Service Areas on 30-Day Mortality in Korea: A Nationwide Retrospective Cross-sectional Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Emergency Service Analysis of the Prognosis Outcomes and Treatment Delay Among ST-Segment Elevation Myocardial Infarction Patients in Emergency Department Based on the Presence of Symptoms Suggestive of COVID-19 [Volume 13, Issue 1, 2024, Pages 1-8]
  • Employee Driven Innovation All Hands on Deck. Transforming the Health System Requires Innovation, Through Individual- and Diffusion Efforts; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Employee-Driven Innovation Required Capabilities for Employee-Driven Innovation to Emerge in Healthcare Organizations; Comment on “Employee-Driven Innovation in Health Organizations: Insights from a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Empowerment Empowerment of Lay Mental Health Workers and Junior Psychologists Online in a Task-Shared, Rural Setting in Kerala, India [Volume 13, Issue 1, 2024, Pages 1-11]
  • Epidemiological A Multifaceted Approach to Health Crisis in the Philippines; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Equitable Partnerships Experiences of Research Coproduction in Uganda; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Equitable Vaccine Distribution Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Equity Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Equity Generating “Différance” or an Ontology That Is Same Old Same Old; Comment on “The Generative Mechanisms of Financial Strain and Financial Well-Being: A Critical Realist Analysis of Ideology and Difference” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Equity To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practiceand Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue [Volume 13, Issue 1, 2024, Pages 1-14]
  • Equity-Focus Equity Lens on Canada’s COVID-19 Response: Review of the Literature [Volume 13, Issue 1, 2024, Pages 1-9]
  • Equity  Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Essential Health Package Pakistan’s Progress on Universal Health Coverage: Lessons Learned in Priority Setting and Challenges Ahead in Reinforcing Primary Healthcare [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-5]
  • Essential Health Services Addressing the UHC Challenge Using the Disease Control Priorities 3 Approach: Lessons Learned and an Overview of the Pakistan Experience [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-10]
  • Essential Packages of Health Services The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-12]
  • Europe Forecasting the Early Impact of COVID-19 on Physician Supply in EU Countries [Volume 13, Issue 1, 2024, Pages 1-11]
  • European Union Continuing Education in Digital Skills for Healthcare Professionals — Mapping of the Current Situation in EU Member States [Volume 13, Issue 1, 2024, Pages 1-7]
  • Evidence-Informed Deliberative Process  The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-8]
  • Evidence-Informed Policy-Making Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions [Volume 13, Issue 1, 2024, Pages 1-9]

F

  • Facilitators & Barriers Value-Based Integrated Care: A Systematic Literature Review [Volume 13, Issue 1, 2024, Pages 1-17]
  • Facilitators and Barriers Building Cross-sectoral Collaborations to Address Perinatal Health Inequities: Insights From the Dutch Healthy Pregnancy 4 All-3 Program [Volume 13, Issue 1, 2024, Pages 1-12]
  • Family Physician System-Based Interventions to Address Physician Burnout: A Qualitative Study of Canadian Family Physicians’ Experiences During the COVID-19 Pandemic [Volume 13, Issue 1, 2024, Pages 1-9]
  • Fast Food Retailer Responses to Public Consultations on the Adoption of Takeaway Management Zones Around Schools: A Longitudinal Qualitative Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Feminist Economics Well-Being Economics – From Slogan to Discipline?; Comment on “Can a Well-Being Economy Save Us?” [Volume 13, Issue 1, 2024, Pages 1-3]
  • First Wave Essential Factors on Effective Response at the Onset of the COVID-19 Pandemic; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Food Advertsing Regulation  Inhibitors and Supporters of Policy Change in the Regulation of Unhealthy Food Marketing in Australia [Volume 13, Issue 1, 2024, Pages 1-9]
  • Food Marketing Policy Inhibitors and Supporters of Policy Change in the Regulation of Unhealthy Food Marketing in Australia [Volume 13, Issue 1, 2024, Pages 1-9]
  • Food Regulation Understanding the Politics of Food Regulation and Public Health: An Analysis of Codex Standard-Setting Processes on Food Labelling [Volume 13, Issue 1, 2024, Pages 1-18]
  • Food Store Intervention A Systems Innovation Perspective on Implementation and Sustainment Barriers for Healthy Food Store Interventions: A Reflexive Monitoring in Action Study in Dutch Supermarkets [Volume 13, Issue 1, 2024, Pages 1-12]
  • Framework Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures [Volume 13, Issue 1, 2024, Pages 1-14]
  • Front-of-Pack Nutrition Labelling Understanding the Politics of Food Regulation and Public Health: An Analysis of Codex Standard-Setting Processes on Food Labelling [Volume 13, Issue 1, 2024, Pages 1-18]

G

  • Gaza The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point [Volume 13, Issue 1, 2024, Pages 1-3]
  • Gaza Centering Local Knowledge to Address the Imbrication of Settler Colonialism and Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Gaza Are Burned Babies and Mass Graves a Global Health Crisis? What Does Decolonization Got to Do With It?; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point?” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Gaza Genocide Confronting the Colonial Roots of Global Health Inequities in Gaza; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Generalizability Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions [Volume 13, Issue 1, 2024, Pages 1-9]
  • Generic Drugs Chinese Physicians’ Preference for Prescribing Brand-Name vs. Generic: A Discrete Choice Experimen [Volume 13, Issue 1, 2024, Pages 1-9]
  • Genocide Are Burned Babies and Mass Graves a Global Health Crisis? What Does Decolonization Got to Do With It?; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point?” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Geographical Typology How Primary Healthcare Sector is Organized at the Territorial Level in France? A Typology of Territorial Structuring [Volume 13, Issue 1, 2024, Pages 1-13]
  • Global Health The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point [Volume 13, Issue 1, 2024, Pages 1-3]
  • Global Health Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-5]
  • Global Health Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Global Health Countering Coloniality in Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Global Health Confronting the Colonial Roots of Global Health Inequities in Gaza; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Global Health Centering Local Knowledge to Address the Imbrication of Settler Colonialism and Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Global Review Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand [Volume 13, Issue 1, 2024, Pages 1-15]
  • Good Quality In-Between Policy Vision and Practical Realities of Primary Healthcare: A Case Study in Rural Northern Sweden [Volume 13, Issue 1, 2024, Pages 1-11]
  • Governance Public-Private Partnerships in Mexico: Implications of Engaging With the Food and Beverage Industry For Public Health Nutrition [Volume 13, Issue 1, 2024, Pages 1-13]
  • Governance Examining the Contextual Factors Influencing Intersectoral Action for the SDGs: Insights From Canadian Federal Policy Leaders [Volume 13, Issue 1, 2024, Pages 1-10]
  • Governance Factors of Power and Equity: Enhancing Our Health System Resilience Research Frameworks; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Governance Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Governance Practices of Trans-National Corporations: The Need to Change Global Economic and Political Norms; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Governance Bringing Trust Building to Life Within Health Policy-Making; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Government Examining the Contextual Factors Influencing Intersectoral Action for the SDGs: Insights From Canadian Federal Policy Leaders [Volume 13, Issue 1, 2024, Pages 1-10]
  • Government Identifying Positive Practices to Institutionalize Social Innovation in the Malawian Health System [Volume 13, Issue 1, 2024, Pages 1-11]
  • Grounded Theory Decentralisation of the Health System Derailed by Organisational Inertia in Machinga, Malawi [Volume 13, Issue 1, 2024, Pages 1-11]
  • Group Model Building Evidence-Informed Surgical Systems Strengthening with Meaningful Stakeholder Involvement in Low-Resource Settings: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]

H

  • Health Narrative Preparedness: Policy-Makers Must Engage With People’s Values and Experiences to Ensure Effective Implementation of Interventions in Health Emergencies; Comment on “Health Preparedness and Narrative Rationality: A Call for Narrative Preparedness” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Health Organizational Culture Relation With Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Activism The Role of Social Movements in Reducing Harmful Corporate Practices; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health Benefit Package Addressing the UHC Challenge Using the Disease Control Priorities 3 Approach: Lessons Learned and an Overview of the Pakistan Experience [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-10]
  • Health Benefit Packages The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-12]
  • Health Canada Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials [Volume 13, Issue 1, 2024, Pages 1-6]
  • Health Disparity Attention to the Registry of Neglected Diseases: Idiopathic Granulomatous Mastitis as an Example [Volume 13, Issue 1, 2024, Pages 1-2]
  • Health Equity Strengthening the Workforce for Equity-Centered Learning Health Systems: Reflections on Embedded Research and Research Generalism; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Insurance Health Insurance Schemes and Their Influences on Healthcare Variation in Asian Countries: A Realist Review and Theory’s Testing in Thailand [Volume 13, Issue 1, 2024, Pages 1-18]
  • Health Outcomes Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021 [Volume 13, Issue 1, 2024, Pages 1-9]
  • Health Policy Intersectoral Partnerships Between Local Governments and Health Organisations in High-Income Contexts: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Health Policy Policy Horses Still Running Around Healthcare Courses: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Health Policy What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers [Volume 13, Issue 1, 2024, Pages 1-10]
  • Health Policy The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign [Volume 13, Issue 1, 2024, Pages 1-9]
  • Health Policy Praxis, Power, and Processes: Youth Participation in Health Policy – A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health Policy The Adaptation of Digital Health Solutions During the COVID-19 Pandemic in Hungary: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Health Policy Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda [Volume 13, Issue 1, 2024, Pages 1-14]
  • Health Policy Learning Health Systems Are Resilient Health Systems Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Policy Research Training it Forward: The Role of Embedded Research Fellows in the Network of Scholars Program in Nova Scotia; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Research Capacity Why Are African Researchers Left Behind in Global Scientific Publications? – A Viewpoint [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Security We Need a Combination of Approaches to Evaluate Health System Resilience; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health Service Area Effect of the Presence of Emergency Departments With 300 or More Hospital Beds in Health Service Areas on 30-Day Mortality in Korea: A Nationwide Retrospective Cross-sectional Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Health Services Accessibility Effect of the Presence of Emergency Departments With 300 or More Hospital Beds in Health Service Areas on 30-Day Mortality in Korea: A Nationwide Retrospective Cross-sectional Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Health Services Administration Effect of the Presence of Emergency Departments With 300 or More Hospital Beds in Health Service Areas on 30-Day Mortality in Korea: A Nationwide Retrospective Cross-sectional Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Health Services Research Reflections on the Health System Impact Fellowship and the Future of Embedded Research; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health Services Research Training it Forward: The Role of Embedded Research Fellows in the Network of Scholars Program in Nova Scotia; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Services  Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021 [Volume 13, Issue 1, 2024, Pages 1-9]
  • Health Subalternity Confronting the Colonial Roots of Global Health Inequities in Gaza; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health System We Need a Combination of Approaches to Evaluate Health System Resilience; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health System Decentralisation of the Health System Derailed by Organisational Inertia in Machinga, Malawi [Volume 13, Issue 1, 2024, Pages 1-11]
  • Health System To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practiceand Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue [Volume 13, Issue 1, 2024, Pages 1-14]
  • Health System Life After the HSIF: Lessons From Diffusion of Innovation for Sustaining the Impact of Embeddedness; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health System Performance We Need a Combination of Approaches to Evaluate Health System Resilience; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health System Resilience We Need a Combination of Approaches to Evaluate Health System Resilience; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health System Resilience Resilience: Now What?; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Health System Resilience How Is Health System Resilience Being Assessed? A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Health System Strengthening Addressing the UHC Challenge Using the Disease Control Priorities 3 Approach: Lessons Learned and an Overview of the Pakistan Experience [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-10]
  • Health Systems Placing Trust at the Heart of Health Policy and Systems [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Systems Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda [Volume 13, Issue 1, 2024, Pages 1-14]
  • Health Systems Factors of Power and Equity: Enhancing Our Health System Resilience Research Frameworks; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Systems Learning From Countries on Measuring and Defining Community-Based Resilience in Health Systems: Voices From Nepal, Sierra Leone, Liberia, and Ethiopia [Volume 13, Issue 1, 2024, Pages 1-12]
  • Health Systems Building Trust and Trustworthiness in Public Institutions: Essential Elements in Placing Trust at the Heart of Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Systems Employee-Driven Innovation as an Approach to Health System Strengthening in LMICs; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Systems Wicked Questions and Perfect Storms; Comment on “From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Health Systems Strengthening Identifying Positive Practices to Institutionalize Social Innovation in the Malawian Health System [Volume 13, Issue 1, 2024, Pages 1-11]
  • Health Technology Assessment Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan’s Essential Package of Health Services [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-9]
  • Health Technology Assessment Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Health Technology Assessment Moving Towards Effective and Efficient Implementation of Evidence-Informed Deliberative Processes for Health Benefit Package Design: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Health Technology Assessment Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions [Volume 13, Issue 1, 2024, Pages 1-9]
  • Health Technology Assessment To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practiceand Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue [Volume 13, Issue 1, 2024, Pages 1-14]
  • Health Utilities Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada [Volume 13, Issue 1, 2024, Pages 1-12]
  • Health Workers Violence Against Health Workers Amidst Brain Drain in Nigeria: An Issue of Concern [Volume 13, Issue 1, 2024, Pages 1-2]
  • Health Workforce Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems [Volume 13, Issue 1, 2024, Pages 1-11]
  • Healthcare Helping Healthcare to Help Itself: A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Healthcare Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World [Volume 13, Issue 1, 2024, Pages 1-3]
  • Healthcare Required Capabilities for Employee-Driven Innovation to Emerge in Healthcare Organizations; Comment on “Employee-Driven Innovation in Health Organizations: Insights from a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Healthcare How Do the Determinants of Collaborative Consumption Influence Its Use in Healthcare? A Managerial Perspective [Volume 13, Issue 1, 2024, Pages 1-16]
  • Healthcare Coopetition Strategy in the Healthcare: Good or Bad? [Volume 13, Issue 1, 2024, Pages 1-3]
  • Healthcare Disparities Effect of the Presence of Emergency Departments With 300 or More Hospital Beds in Health Service Areas on 30-Day Mortality in Korea: A Nationwide Retrospective Cross-sectional Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Healthcare Quality “Caught in Each Other’s Traps”: Factors Perpetuating Incentive-Linked Prescribing Deals Between Physicians and the Pharmaceutical Industry [Volume 13, Issue 1, 2024, Pages 1-11]
  • Healthcare Retirees A Need for Honoring Healthcare Retirees: Proposed Recommendations [Volume 13, Issue 1, 2024, Pages 1-2]
  • Healthcare System Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021 [Volume 13, Issue 1, 2024, Pages 1-9]
  • Healthcare Systems How Primary Healthcare Sector is Organized at the Territorial Level in France? A Typology of Territorial Structuring [Volume 13, Issue 1, 2024, Pages 1-13]
  • Healthcare Variation Health Insurance Schemes and Their Influences on Healthcare Variation in Asian Countries: A Realist Review and Theory’s Testing in Thailand [Volume 13, Issue 1, 2024, Pages 1-18]
  • Healthcare Workforce Activating Mechanisms Through Employee-Driven Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Healthcare Workforce Planning Forecasting the Early Impact of COVID-19 on Physician Supply in EU Countries [Volume 13, Issue 1, 2024, Pages 1-11]
  • Hierarchical Bayesian Meta-analysis  Spatial Distribution and Birth Prevalence of Congenital Heart Disease in Iran: A Systematic Review and Hierarchical Bayesian Meta-analysis [Volume 13, Issue 1, 2024, Pages 1-11]
  • High-Cost Drug Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand [Volume 13, Issue 1, 2024, Pages 1-15]
  • High-Cost Drugs Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • High-Cost Patients Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China [Volume 13, Issue 1, 2024, Pages 1-11]
  • High-Income Country Hoarding Vaccines or Hedging Vaccine R&D Risks? — Motivation for Overbooking COVID-19 Vaccines in High-Income Countries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Honoring A Need for Honoring Healthcare Retirees: Proposed Recommendations [Volume 13, Issue 1, 2024, Pages 1-2]
  • Hospital Design Innovative Models of Care for Hospitals of the Future [Volume 13, Issue 1, 2024, Pages 1-4]
  • Hospital Management How Does Management Matter for Hospital Performance? Evidence From the Global Hospital Management Survey in China [Volume 13, Issue 1, 2024, Pages 1-9]
  • Hospital Performance How Does Management Matter for Hospital Performance? Evidence From the Global Hospital Management Survey in China [Volume 13, Issue 1, 2024, Pages 1-9]
  • Hospital-Physician Relationships Construct Clarity in Physician-Hospital Alignment: The Need for Precision in Definition, Measurement, and Management; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Hospitals Can’t Contracting Be Relational?; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Human-Centered Design Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens [Volume 13, Issue 1, 2024, Pages 1-12]
  • Human-Resource Management Identifying Positive Practices to Institutionalize Social Innovation in the Malawian Health System [Volume 13, Issue 1, 2024, Pages 1-11]
  • Human-Resources Employee-Driven Innovation as an Approach to Health System Strengthening in LMICs; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Hungary The Adaptation of Digital Health Solutions During the COVID-19 Pandemic in Hungary: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-9]

I

  • Ideology Generating “Différance” or an Ontology That Is Same Old Same Old; Comment on “The Generative Mechanisms of Financial Strain and Financial Well-Being: A Critical Realist Analysis of Ideology and Difference” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Impact Research Coproduction: How Can Coproduction Teams Increase Traffic on the Pathway to Impact?; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Implementation Helping Healthcare to Help Itself: A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Implementation Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems [Volume 13, Issue 1, 2024, Pages 1-11]
  • Implementation A Systems Innovation Perspective on Implementation and Sustainment Barriers for Healthy Food Store Interventions: A Reflexive Monitoring in Action Study in Dutch Supermarkets [Volume 13, Issue 1, 2024, Pages 1-12]
  • Implementation Activating Mechanisms Through Employee-Driven Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Implementation A Co-production Values and Principles Compass to Guide Along the Underused Pathway; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Implementation Science What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers [Volume 13, Issue 1, 2024, Pages 1-10]
  • Implementation Science Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-5]
  • Implementation Science Training an Embedded Workforce to Realize Health System Impacts and the Promise of Learning Health Systems; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Implementation Science An Exploration of the Utility and Impacts of Implementation Science Strategies by Cancer Registries for Healthcare Improvement: A Systematic Review [Volume 13, Issue 1, 2024, Pages 1-12]
  • Implementation Science Research Coproduction: How Can Coproduction Teams Increase Traffic on the Pathway to Impact?; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Implementation  Research Coproduction: An Underused Pathway to Impact [Volume 13, Issue 1, 2024, Pages 1-4]
  • Inclusion Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Indigenous health Centering Local Knowledge to Address the Imbrication of Settler Colonialism and Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Industry Influence Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-20]
  • Industry Monitoring How Could We Establish Monitoring and Surveillance of Health-Harming Corporations and Can Governments Be Trusted to Do It?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Inertia Decentralisation of the Health System Derailed by Organisational Inertia in Machinga, Malawi [Volume 13, Issue 1, 2024, Pages 1-11]
  • Infants and Young Children Understanding the Politics of Food Regulation and Public Health: An Analysis of Codex Standard-Setting Processes on Food Labelling [Volume 13, Issue 1, 2024, Pages 1-18]
  • Influencing Factors Chinese Physicians’ Preference for Prescribing Brand-Name vs. Generic: A Discrete Choice Experimen [Volume 13, Issue 1, 2024, Pages 1-9]
  • Innovation Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World [Volume 13, Issue 1, 2024, Pages 1-3]
  • Innovation Organizational Culture Relation With Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Innovation Activating Mechanisms Through Employee-Driven Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Innovation Identifying Positive Practices to Institutionalize Social Innovation in the Malawian Health System [Volume 13, Issue 1, 2024, Pages 1-11]
  • Institutional Policy Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Integrated Care The Effect of Integrated Care After Discharge From Hospitals on Outcomes Among Korean Older Adults [Volume 13, Issue 1, 2024, Pages 1-8]
  • Integrated Care Innovative Models of Care for Hospitals of the Future [Volume 13, Issue 1, 2024, Pages 1-4]
  • Integrated Care Value-Based Integrated Care: A Systematic Literature Review [Volume 13, Issue 1, 2024, Pages 1-17]
  • Integrated Care Next Steps for Medical Specialist Enterprises in the Netherlands: Building Strong Clinical Governance and Leadership; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Integrated Care In-Between Policy Vision and Practical Realities of Primary Healthcare: A Case Study in Rural Northern Sweden [Volume 13, Issue 1, 2024, Pages 1-11]
  • Integrated Care Wicked Questions and Perfect Storms; Comment on “From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Integrated Knowledge Translation Research Coproduction: An Underused Pathway to Impact [Volume 13, Issue 1, 2024, Pages 1-4]
  • Integrated Knowledge Translation Fostering Experiential Learning and Evidence-Informed Impact in Health Systems: Reflections From a Canadian Health System Impact Fellow [Volume 13, Issue 1, 2024, Pages 1-6]
  • Integrated Knowledge Translation Balancing Power and Co-production; Comment on “Research Co-production: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Integrated Knowledge Translation A Co-production Values and Principles Compass to Guide Along the Underused Pathway; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Interrupted Time Series Impact of the Diagnosis-Intervention Packet Payment Reform on Provider Behavior in China: A Controlled Interrupted Time Series Study [Volume 13, Issue 1, 2024, Pages 1-10]
  • Interrupted Time Series Analysis Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis [Volume 13, Issue 1, 2024, Pages 1-10]
  • Intersectoral Action Examining the Contextual Factors Influencing Intersectoral Action for the SDGs: Insights From Canadian Federal Policy Leaders [Volume 13, Issue 1, 2024, Pages 1-10]
  • Intersectoral Collaboration Intersectoral Partnerships Between Local Governments and Health Organisations in High-Income Contexts: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Involvement Frontrunning, Free-Riding and Over-Aspiring: A Case Study Exploring How Configurations of Involvement, Social Comparison and Organizational Goal Attainment Affect Perceived Network Goal Attainment [Volume 13, Issue 1, 2024, Pages 1-13]
  • Iran Spatial Distribution and Birth Prevalence of Congenital Heart Disease in Iran: A Systematic Review and Hierarchical Bayesian Meta-analysis [Volume 13, Issue 1, 2024, Pages 1-11]
  • Iran Attention to the Registry of Neglected Diseases: Idiopathic Granulomatous Mastitis as an Example [Volume 13, Issue 1, 2024, Pages 1-2]
  • Iran  Exploring the County Level Mortality Pattern Variations in Rural Areas of Iran (2006-2016) [Volume 13, Issue 1, 2024, Pages 1-8]
  • Isolation Analysis of the Prognosis Outcomes and Treatment Delay Among ST-Segment Elevation Myocardial Infarction Patients in Emergency Department Based on the Presence of Symptoms Suggestive of COVID-19 [Volume 13, Issue 1, 2024, Pages 1-8]
  • Italy Essential Factors on Effective Response at the Onset of the COVID-19 Pandemic; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Italy A Multifaceted Approach to Health Crisis in the Philippines; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Italy Health and Social Care Inequalities During the First Wave of COVID-19 in Italy; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]

J

  • Japan The Economic Rationale for Healthcare Reform [Volume 13, Issue 1, 2024, Pages 1-3]
  • Japan  Technical Efficiency of Prevention Services for Functional Dependency in Japan’s Public Long-term Care Insurance System: An Ecological Study [Volume 13, Issue 1, 2024, Pages 1-8]

K

  • Kenya Why Was the Policy Idea on the Health Benefits Package Advisory Panel Gazetted in Kenya? A Retrospective Policy Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Knowledge Co-production A Co-production Values and Principles Compass to Guide Along the Underused Pathway; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Knowledge Translation Standing on the Shoulder of Power, Representation and Relational Trust; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Knowledge Translation An Exploration of the Utility and Impacts of Implementation Science Strategies by Cancer Registries for Healthcare Improvement: A Systematic Review [Volume 13, Issue 1, 2024, Pages 1-12]
  • Knowledge Translation Research Coproduction: How Can Coproduction Teams Increase Traffic on the Pathway to Impact?; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Knowledge Translation Balancing Power and Co-production; Comment on “Research Co-production: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Knowledge-to-Action Life After the HSIF: Lessons From Diffusion of Innovation for Sustaining the Impact of Embeddedness; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Korea Analysis of the Prognosis Outcomes and Treatment Delay Among ST-Segment Elevation Myocardial Infarction Patients in Emergency Department Based on the Presence of Symptoms Suggestive of COVID-19 [Volume 13, Issue 1, 2024, Pages 1-8]
  • Korea Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea [Volume 13, Issue 1, 2024, Pages 1-9]

L

  • Leadership Examining the Contextual Factors Influencing Intersectoral Action for the SDGs: Insights From Canadian Federal Policy Leaders [Volume 13, Issue 1, 2024, Pages 1-10]
  • Leadership Required Capabilities for Employee-Driven Innovation to Emerge in Healthcare Organizations; Comment on “Employee-Driven Innovation in Health Organizations: Insights from a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Learning Health System An Exploration of the Utility and Impacts of Implementation Science Strategies by Cancer Registries for Healthcare Improvement: A Systematic Review [Volume 13, Issue 1, 2024, Pages 1-12]
  • Learning Health Systems Strengthening the Workforce for Equity-Centered Learning Health Systems: Reflections on Embedded Research and Research Generalism; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Learning Health Systems Learning Health Systems Are Resilient Health Systems Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Learning Health Systems Training an Embedded Workforce to Realize Health System Impacts and the Promise of Learning Health Systems; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Learning Health Systems Reflections on the Health System Impact Fellowship and the Future of Embedded Research; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Learning Health Systems Training it Forward: The Role of Embedded Research Fellows in the Network of Scholars Program in Nova Scotia; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Legitimacy Moving Towards Effective and Efficient Implementation of Evidence-Informed Deliberative Processes for Health Benefit Package Design: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Lived Experience Balancing Power and Co-production; Comment on “Research Co-production: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Lobbying Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures [Volume 13, Issue 1, 2024, Pages 1-14]
  • Local Government Intersectoral Partnerships Between Local Governments and Health Organisations in High-Income Contexts: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Local Healthcare In-Between Policy Vision and Practical Realities of Primary Healthcare: A Case Study in Rural Northern Sweden [Volume 13, Issue 1, 2024, Pages 1-11]
  • Long-term Care Insurance Technical Efficiency of Prevention Services for Functional Dependency in Japan’s Public Long-term Care Insurance System: An Ecological Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Low- and Middle-Income Countries Governing Political Realities in NCD Agenda Setting in LMICs: A Case of the Carrot and the Stick?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries: A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Low-Value Care Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors [Volume 13, Issue 1, 2024, Pages 1-11]
  • Low-Value Care Discrepancies Among Hospitals and Regions in the Provision of Low-Value Care [Volume 13, Issue 1, 2024, Pages 1-10]
  • Lung Cancer Screening Public Heterogeneous Preferences for Low-Dose Computed Tomography Lung Cancer Screening Service Delivery in Western China: A Discrete Choice Experiment [Volume 13, Issue 1, 2024, Pages 1-11]

M

  • Malaysia Entry of Migrant Workers to Malaysia: Consideration to Implement Mass Drug Administration Against Intestinal Parasitic Infections [Volume 13, Issue 1, 2024, Pages 1-5]
  • Medical Device Legislation Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Medical Device Software Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Medical Errors Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens [Volume 13, Issue 1, 2024, Pages 1-12]
  • Medical Practice Health Insurance Schemes and Their Influences on Healthcare Variation in Asian Countries: A Realist Review and Theory’s Testing in Thailand [Volume 13, Issue 1, 2024, Pages 1-18]
  • Medical Specialist Enterprises Next Steps for Medical Specialist Enterprises in the Netherlands: Building Strong Clinical Governance and Leadership; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Medical Specialist Enterprises Can’t Contracting Be Relational?; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Medicines Regulatory Harmonisation Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment [Volume 13, Issue 1, 2024, Pages 1-11]
  • Mentorship Training it Forward: The Role of Embedded Research Fellows in the Network of Scholars Program in Nova Scotia; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Meso-level The Meso-Level in Quality Improvement: Perspectives From a Maternal-Neonatal Health Partnership in South Africa [Volume 13, Issue 1, 2024, Pages 1-9]
  • Migrant Workers  Entry of Migrant Workers to Malaysia: Consideration to Implement Mass Drug Administration Against Intestinal Parasitic Infections [Volume 13, Issue 1, 2024, Pages 1-5]
  • Minimum Dataset Attention to the Registry of Neglected Diseases: Idiopathic Granulomatous Mastitis as an Example [Volume 13, Issue 1, 2024, Pages 1-2]
  • Mixed Methods Helping Healthcare to Help Itself: A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Mixed Methods  “Caught in Each Other’s Traps”: Factors Perpetuating Incentive-Linked Prescribing Deals Between Physicians and the Pharmaceutical Industry [Volume 13, Issue 1, 2024, Pages 1-11]
  • Modelling Policy Horses Still Running Around Healthcare Courses: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Monitoring A Systems Innovation Perspective on Implementation and Sustainment Barriers for Healthy Food Store Interventions: A Reflexive Monitoring in Action Study in Dutch Supermarkets [Volume 13, Issue 1, 2024, Pages 1-12]
  • Monitoring Political Considerations When Monitoring the Commercial Determinants of Health; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Monitoring and Evaluation Moving Towards Effective and Efficient Implementation of Evidence-Informed Deliberative Processes for Health Benefit Package Design: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Monitoring and Evaluation Learning From Countries on Measuring and Defining Community-Based Resilience in Health Systems: Voices From Nepal, Sierra Leone, Liberia, and Ethiopia [Volume 13, Issue 1, 2024, Pages 1-12]
  • More-Than-Human Energy Is Power; Comment on “Energy as a Social and Commercial Determinant of Health: A Qualitative Study of Australian Policy” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Mortality Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021 [Volume 13, Issue 1, 2024, Pages 1-9]
  • Mortality Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea [Volume 13, Issue 1, 2024, Pages 1-9]
  • Mortality Rate Exploring the County Level Mortality Pattern Variations in Rural Areas of Iran (2006-2016) [Volume 13, Issue 1, 2024, Pages 1-8]
  • Mortality  Effect of the Presence of Emergency Departments With 300 or More Hospital Beds in Health Service Areas on 30-Day Mortality in Korea: A Nationwide Retrospective Cross-sectional Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Multi-Dimensional Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World [Volume 13, Issue 1, 2024, Pages 1-3]
  • Multinomial Logistic Regression Negative Emotions Are Associated With Older Self-perceived Age: A Cross-section Study From the UK Biobank [Volume 13, Issue 1, 2024, Pages 1-8]
  • Multiple Streams Theory Why Was the Policy Idea on the Health Benefits Package Advisory Panel Gazetted in Kenya? A Retrospective Policy Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Musculoskeletal Wicked Questions and Perfect Storms; Comment on “From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Myocardial Infarction Analysis of the Prognosis Outcomes and Treatment Delay Among ST-Segment Elevation Myocardial Infarction Patients in Emergency Department Based on the Presence of Symptoms Suggestive of COVID-19 [Volume 13, Issue 1, 2024, Pages 1-8]

N

  • Narrative Preparedness Narrative Preparedness: Policy-Makers Must Engage With People’s Values and Experiences to Ensure Effective Implementation of Interventions in Health Emergencies; Comment on “Health Preparedness and Narrative Rationality: A Call for Narrative Preparedness” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Negative Emotions Negative Emotions Are Associated With Older Self-perceived Age: A Cross-section Study From the UK Biobank [Volume 13, Issue 1, 2024, Pages 1-8]
  • Netherlands A Systems Innovation Perspective on Implementation and Sustainment Barriers for Healthy Food Store Interventions: A Reflexive Monitoring in Action Study in Dutch Supermarkets [Volume 13, Issue 1, 2024, Pages 1-12]
  • Netherlands Can’t Contracting Be Relational?; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Network Goal Attainment Frontrunning, Free-Riding and Over-Aspiring: A Case Study Exploring How Configurations of Involvement, Social Comparison and Organizational Goal Attainment Affect Perceived Network Goal Attainment [Volume 13, Issue 1, 2024, Pages 1-13]
  • New Zealand Next Steps for Medical Specialist Enterprises in the Netherlands: Building Strong Clinical Governance and Leadership; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Nigeria Violence Against Health Workers Amidst Brain Drain in Nigeria: An Issue of Concern [Volume 13, Issue 1, 2024, Pages 1-2]
  • Non-Communicable Diseases Governing Political Realities in NCD Agenda Setting in LMICs: A Case of the Carrot and the Stick?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries: A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Non-communicable Diseases  Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-17]
  • Normative Beliefs How Do the Determinants of Collaborative Consumption Influence Its Use in Healthcare? A Managerial Perspective [Volume 13, Issue 1, 2024, Pages 1-16]
  • Norms Practices of Trans-National Corporations: The Need to Change Global Economic and Political Norms; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • North-South Collaboration Experiences of Research Coproduction in Uganda; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Northern Ontario Strengthening the Workforce for Equity-Centered Learning Health Systems: Reflections on Embedded Research and Research Generalism; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Nurse Practitioner Integration Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems [Volume 13, Issue 1, 2024, Pages 1-11]
  • Nurse practitioner Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems [Volume 13, Issue 1, 2024, Pages 1-11]
  • Nursing Development of a Taxonomy of Policy Interventions for Integrating Nurse Practitioners into Health Systems [Volume 13, Issue 1, 2024, Pages 1-11]
  • Nutrition Programs Public-Private Partnerships in Mexico: Implications of Engaging With the Food and Beverage Industry For Public Health Nutrition [Volume 13, Issue 1, 2024, Pages 1-13]

O

  • Obesity Retailer Responses to Public Consultations on the Adoption of Takeaway Management Zones Around Schools: A Longitudinal Qualitative Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Older Adults The Effect of Integrated Care After Discharge From Hospitals on Outcomes Among Korean Older Adults [Volume 13, Issue 1, 2024, Pages 1-8]
  • Organisational Governance Can’t Contracting Be Relational?; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Organizational Behaviour Activating Mechanisms Through Employee-Driven Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Organizational Culture Organizational Culture Relation With Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Organizational Culture Employee-Driven Innovation as an Approach to Health System Strengthening in LMICs; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Organizational Goal Attainment Frontrunning, Free-Riding and Over-Aspiring: A Case Study Exploring How Configurations of Involvement, Social Comparison and Organizational Goal Attainment Affect Perceived Network Goal Attainment [Volume 13, Issue 1, 2024, Pages 1-13]
  • Organized Groups Is a Government-Led Approach to Surveil Unhealthy Commodity Industries Feasible?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Outcomes The Effect of Integrated Care After Discharge From Hospitals on Outcomes Among Korean Older Adults [Volume 13, Issue 1, 2024, Pages 1-8]
  • Overbook Hoarding Vaccines or Hedging Vaccine R&D Risks? — Motivation for Overbooking COVID-19 Vaccines in High-Income Countries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Overuse Discrepancies Among Hospitals and Regions in the Provision of Low-Value Care [Volume 13, Issue 1, 2024, Pages 1-10]
  • Overuse  Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors [Volume 13, Issue 1, 2024, Pages 1-11]

P

  • Paediatrics Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Pakistan The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-8]
  • Pakistan The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-12]
  • Pakistan Pakistan’s Progress on Universal Health Coverage: Lessons Learned in Priority Setting and Challenges Ahead in Reinforcing Primary Healthcare [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-5]
  • Pakistan “Caught in Each Other’s Traps”: Factors Perpetuating Incentive-Linked Prescribing Deals Between Physicians and the Pharmaceutical Industry [Volume 13, Issue 1, 2024, Pages 1-11]
  • Pakistan  Addressing the UHC Challenge Using the Disease Control Priorities 3 Approach: Lessons Learned and an Overview of the Pakistan Experience [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-10]
  • Pakistan  Costing Interventions for Developing an Essential Package of Health Services: Application of a Rapid Method and Results From Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-17]
  • Palestine The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point [Volume 13, Issue 1, 2024, Pages 1-3]
  • Palestine Are Burned Babies and Mass Graves a Global Health Crisis? What Does Decolonization Got to Do With It?; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point?” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Pandemic Essential Factors on Effective Response at the Onset of the COVID-19 Pandemic; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pandemic Generating “Différance” or an Ontology That Is Same Old Same Old; Comment on “The Generative Mechanisms of Financial Strain and Financial Well-Being: A Critical Realist Analysis of Ideology and Difference” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Pandemic Accord Profits First, Health Second: The Pharmaceutical Industry and the Global South; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pandemic Agreement Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pandemic Preparedness Equity Lens on Canada’s COVID-19 Response: Review of the Literature [Volume 13, Issue 1, 2024, Pages 1-9]
  • Pandemic Preparedness Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pandemic Preparedness Learning Health Systems Are Resilient Health Systems Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pandemic-Related Products Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Parasitic Infections Entry of Migrant Workers to Malaysia: Consideration to Implement Mass Drug Administration Against Intestinal Parasitic Infections [Volume 13, Issue 1, 2024, Pages 1-5]
  • Parliamentary Committees Tobacco Industry Engagement in the House of Commons Science and Technology Select Committee E-Cigarettes Inquiry [Volume 13, Issue 1, 2024, Pages 1-10]
  • Participatory Research Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-20]
  • Participatory Research Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-17]
  • Partnership The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign [Volume 13, Issue 1, 2024, Pages 1-9]
  • Patient Centred Why Systems Thinking is Needed to Center Trust in Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Patient Safety Analysis of the Prognosis Outcomes and Treatment Delay Among ST-Segment Elevation Myocardial Infarction Patients in Emergency Department Based on the Presence of Symptoms Suggestive of COVID-19 [Volume 13, Issue 1, 2024, Pages 1-8]
  • Patient Safety Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens [Volume 13, Issue 1, 2024, Pages 1-12]
  • Patient Segmentation Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China [Volume 13, Issue 1, 2024, Pages 1-11]
  • Patient-Centered Achieving Diagnostic Excellence: Roadmaps to Develop and Use Patient-Reported Measures With an Equity Lens [Volume 13, Issue 1, 2024, Pages 1-12]
  • Patient-Centredness  Placing Trust at the Heart of Health Policy and Systems [Volume 13, Issue 1, 2024, Pages 1-4]
  • Patient-Oriented Research Grappling With the Inclusion of Patients and the Public in Consensus Building: A Commentary on Inclusion, Safety, and Accessibility; Comment on “Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Payment Reform Impact of the Diagnosis-Intervention Packet Payment Reform on Provider Behavior in China: A Controlled Interrupted Time Series Study [Volume 13, Issue 1, 2024, Pages 1-10]
  • Performance Bringing Trust Building to Life Within Health Policy-Making; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Perinatal Health Inequities Building Cross-sectoral Collaborations to Address Perinatal Health Inequities: Insights From the Dutch Healthy Pregnancy 4 All-3 Program [Volume 13, Issue 1, 2024, Pages 1-12]
  • Person-Centred Care In-Between Policy Vision and Practical Realities of Primary Healthcare: A Case Study in Rural Northern Sweden [Volume 13, Issue 1, 2024, Pages 1-11]
  • Pharmaceutical Companies Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pharmaceutical Industry Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials [Volume 13, Issue 1, 2024, Pages 1-6]
  • Pharmaceutical Industry Profits First, Health Second: The Pharmaceutical Industry and the Global South; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pharmaceutical Industry Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pharmaceutical Marketing “Caught in Each Other’s Traps”: Factors Perpetuating Incentive-Linked Prescribing Deals Between Physicians and the Pharmaceutical Industry [Volume 13, Issue 1, 2024, Pages 1-11]
  • Pharmaceuticals Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World [Volume 13, Issue 1, 2024, Pages 1-3]
  • Pharmaceuticals The Economic Rationale for Healthcare Reform [Volume 13, Issue 1, 2024, Pages 1-3]
  • Phase IV Trials Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials [Volume 13, Issue 1, 2024, Pages 1-6]
  • Philippines A Multifaceted Approach to Health Crisis in the Philippines; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Physician Reimbursement Can’t Contracting Be Relational?; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Physician Shortage  Forecasting the Early Impact of COVID-19 on Physician Supply in EU Countries [Volume 13, Issue 1, 2024, Pages 1-11]
  • Physician-Hospital Alignment Construct Clarity in Physician-Hospital Alignment: The Need for Precision in Definition, Measurement, and Management; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Planet Energy Is Power; Comment on “Energy as a Social and Commercial Determinant of Health: A Qualitative Study of Australian Policy” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Policy Examining the Contextual Factors Influencing Intersectoral Action for the SDGs: Insights From Canadian Federal Policy Leaders [Volume 13, Issue 1, 2024, Pages 1-10]
  • Policy Narrative Preparedness: Policy-Makers Must Engage With People’s Values and Experiences to Ensure Effective Implementation of Interventions in Health Emergencies; Comment on “Health Preparedness and Narrative Rationality: A Call for Narrative Preparedness” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Policy Bringing Trust Building to Life Within Health Policy-Making; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Policy Wicked Questions and Perfect Storms; Comment on “From Local Action to Global Policy: A Comparative Policy Content Analysis of National Policies to Address Musculoskeletal Health to Inform Global Policy Development” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Policy Analysis Why Was the Policy Idea on the Health Benefits Package Advisory Panel Gazetted in Kenya? A Retrospective Policy Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Policy Planning Equity Lens on Canada’s COVID-19 Response: Review of the Literature [Volume 13, Issue 1, 2024, Pages 1-9]
  • Policy Process Praxis, Power, and Processes: Youth Participation in Health Policy – A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Policy Processes Policy Horses Still Running Around Healthcare Courses: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Political Economy Can a Well-Being Economy Save Us? [Volume 13, Issue 1, 2024, Pages 1-6]
  • Political Economy of Health Practices of Trans-National Corporations: The Need to Change Global Economic and Political Norms; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Political Feasibility Political Considerations When Monitoring the Commercial Determinants of Health; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Political Prioritization Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Politics Energy Is Power; Comment on “Energy as a Social and Commercial Determinant of Health: A Qualitative Study of Australian Policy” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Politics of Health  The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point [Volume 13, Issue 1, 2024, Pages 1-3]
  • Population Health Health and Social Care Inequalities During the First Wave of COVID-19 in Italy; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Post-growth Well-Being Economics – From Slogan to Discipline?; Comment on “Can a Well-Being Economy Save Us?” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Post-growth Economics Can a Well-Being Economy Save Us? [Volume 13, Issue 1, 2024, Pages 1-6]
  • Postmarket Trials Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-IndustryFunded Trials [Volume 13, Issue 1, 2024, Pages 1-6]
  • Potentially Preventable Hospitalization Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China [Volume 13, Issue 1, 2024, Pages 1-11]
  • Power Practices of Trans-National Corporations: The Need to Change Global Economic and Political Norms; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Power Energy Is Power; Comment on “Energy as a Social and Commercial Determinant of Health: A Qualitative Study of Australian Policy” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Power Balancing Power and Co-production; Comment on “Research Co-production: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Pragmatism Generating “Différance” or an Ontology That Is Same Old Same Old; Comment on “The Generative Mechanisms of Financial Strain and Financial Well-Being: A Critical Realist Analysis of Ideology and Difference” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Predictive Medicine Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We There Yet? A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Preference Heterogeneity Public Heterogeneous Preferences for Low-Dose Computed Tomography Lung Cancer Screening Service Delivery in Western China: A Discrete Choice Experiment [Volume 13, Issue 1, 2024, Pages 1-11]
  • Preparedness Planning We Need a Combination of Approaches to Evaluate Health System Resilience; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic [Volume 13, Issue 1, 2024, Pages 1-3]
  • Prescribing Behavior Chinese Physicians’ Preference for Prescribing Brand-Name vs. Generic: A Discrete Choice Experimen [Volume 13, Issue 1, 2024, Pages 1-9]
  • Pressure Injury Economic Evaluation of Multilayer Silicone-Adhesive Polyurethane Foam Dressing for the Prevention of Pressure Ulcers in At-Risk Hospitalized Patients: US and Italian Perspective [Volume 13, Issue 1, 2024, Pages 1-8]
  • Pressure Ulcer Economic Evaluation of Multilayer Silicone-Adhesive Polyurethane Foam Dressing for the Prevention of Pressure Ulcers in At-Risk Hospitalized Patients: US and Italian Perspective [Volume 13, Issue 1, 2024, Pages 1-8]
  • Preventable Inpatient Cost Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China [Volume 13, Issue 1, 2024, Pages 1-11]
  • Prevention Economic Evaluation of Multilayer Silicone-Adhesive Polyurethane Foam Dressing for the Prevention of Pressure Ulcers in At-Risk Hospitalized Patients: US and Italian Perspective [Volume 13, Issue 1, 2024, Pages 1-8]
  • Preventive Benefits Technical Efficiency of Prevention Services for Functional Dependency in Japan’s Public Long-term Care Insurance System: An Ecological Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Price Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China [Volume 13, Issue 1, 2024, Pages 1-10]
  • Primary Care How Primary Healthcare Sector is Organized at the Territorial Level in France? A Typology of Territorial Structuring [Volume 13, Issue 1, 2024, Pages 1-13]
  • Primary Care System-Based Interventions to Address Physician Burnout: A Qualitative Study of Canadian Family Physicians’ Experiences During the COVID-19 Pandemic [Volume 13, Issue 1, 2024, Pages 1-9]
  • Primary Care Next Steps for Medical Specialist Enterprises in the Netherlands: Building Strong Clinical Governance and Leadership; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Primary Care Networks Frontrunning, Free-Riding and Over-Aspiring: A Case Study Exploring How Configurations of Involvement, Social Comparison and Organizational Goal Attainment Affect Perceived Network Goal Attainment [Volume 13, Issue 1, 2024, Pages 1-13]
  • Primary Healthcare Pakistan’s Progress on Universal Health Coverage: Lessons Learned in Priority Setting and Challenges Ahead in Reinforcing Primary Healthcare [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-5]
  • Primary Healthcare Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-5]
  • Prioritisation Evidence-Informed Surgical Systems Strengthening with Meaningful Stakeholder Involvement in Low-Resource Settings: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Priority Setting The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-8]
  • Priority Setting Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan’s Essential Package of Health Services [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-9]
  • Priority Setting The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-12]
  • Private Healthcare “Caught in Each Other’s Traps”: Factors Perpetuating Incentive-Linked Prescribing Deals Between Physicians and the Pharmaceutical Industry [Volume 13, Issue 1, 2024, Pages 1-11]
  • Professional Development Training it Forward: The Role of Embedded Research Fellows in the Network of Scholars Program in Nova Scotia; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Proposed Recommendations A Need for Honoring Healthcare Retirees: Proposed Recommendations [Volume 13, Issue 1, 2024, Pages 1-2]
  • Provider Behavior Impact of the Diagnosis-Intervention Packet Payment Reform on Provider Behavior in China: A Controlled Interrupted Time Series Study [Volume 13, Issue 1, 2024, Pages 1-10]
  • Public Engagement Standing on the Shoulder of Power, Representation and Relational Trust; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Public Health What Lies Beneath? The Role of Community Engagement in Translating COVID-19 Research Findings to Policy-Makers [Volume 13, Issue 1, 2024, Pages 1-10]
  • Public Health The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign [Volume 13, Issue 1, 2024, Pages 1-9]
  • Public Health Generating “Différance” or an Ontology That Is Same Old Same Old; Comment on “The Generative Mechanisms of Financial Strain and Financial Well-Being: A Critical Realist Analysis of Ideology and Difference” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Public Health Understanding the Politics of Food Regulation and Public Health: An Analysis of Codex Standard-Setting Processes on Food Labelling [Volume 13, Issue 1, 2024, Pages 1-18]
  • Public Health  How Primary Healthcare Sector is Organized at the Territorial Level in France? A Typology of Territorial Structuring [Volume 13, Issue 1, 2024, Pages 1-13]
  • Public Institutions Building Trust and Trustworthiness in Public Institutions: Essential Elements in Placing Trust at the Heart of Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Public Involvement Standing on the Shoulder of Power, Representation and Relational Trust; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Public health surveillance Is a Government-Led Approach to Surveil Unhealthy Commodity Industries Feasible?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Public health surveillance Governing Political Realities in NCD Agenda Setting in LMICs: A Case of the Carrot and the Stick?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries: A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Public-Private Partnerships Public-Private Partnerships in Mexico: Implications of Engaging With the Food and Beverage Industry For Public Health Nutrition [Volume 13, Issue 1, 2024, Pages 1-13]

Q

  • Qualitative Research Innovative Models of Care for Hospitals of the Future [Volume 13, Issue 1, 2024, Pages 1-4]
  • Qualitative Research System-Based Interventions to Address Physician Burnout: A Qualitative Study of Canadian Family Physicians’ Experiences During the COVID-19 Pandemic [Volume 13, Issue 1, 2024, Pages 1-9]
  • Quality Quality Measurement in Shanghai From a Global Perspective; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-5]
  • Quality Improvement The Meso-Level in Quality Improvement: Perspectives From a Maternal-Neonatal Health Partnership in South Africa [Volume 13, Issue 1, 2024, Pages 1-9]
  • Quality Improvement An Exploration of the Utility and Impacts of Implementation Science Strategies by Cancer Registries for Healthcare Improvement: A Systematic Review [Volume 13, Issue 1, 2024, Pages 1-12]
  • Quality control Attention to the Registry of Neglected Diseases: Idiopathic Granulomatous Mastitis as an Example [Volume 13, Issue 1, 2024, Pages 1-2]

R

  • Rare/Orphan Diseases Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Realist Evaluation Required Capabilities for Employee-Driven Innovation to Emerge in Healthcare Organizations; Comment on “Employee-Driven Innovation in Health Organizations: Insights from a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Regulation Multi-dimensional Perspective Pharmaceutical Evaluation: A Path to Enhancing Healthcare Decision-Making in Real-World [Volume 13, Issue 1, 2024, Pages 1-3]
  • Rehabilitation Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda [Volume 13, Issue 1, 2024, Pages 1-14]
  • Reimbursement Decision Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China [Volume 13, Issue 1, 2024, Pages 1-10]
  • Reimbursement Lag Association of Launch Price and Clinical Value With Reimbursement Decisions for Anticancer Drugs in China [Volume 13, Issue 1, 2024, Pages 1-10]
  • Reimbursement Policies Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis [Volume 13, Issue 1, 2024, Pages 1-10]
  • Relational Contracting Can’t Contracting Be Relational?; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Religiosity A Multifaceted Approach to Health Crisis in the Philippines; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Research Experiences of Research Coproduction in Uganda; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Research Co-Production A Co-production Values and Principles Compass to Guide Along the Underused Pathway; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Research Coproduction Research Coproduction: An Underused Pathway to Impact [Volume 13, Issue 1, 2024, Pages 1-4]
  • Research Framework Factors of Power and Equity: Enhancing Our Health System Resilience Research Frameworks; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Research Impacts Training an Embedded Workforce to Realize Health System Impacts and the Promise of Learning Health Systems; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Research and Development  Profits First, Health Second: The Pharmaceutical Industry and the Global South; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Residents Unravelling Low-Value Care Decision-Making: Residents’ Perspectives on the Influence of Contextual Factors [Volume 13, Issue 1, 2024, Pages 1-11]
  • Resilience Placing Trust at the Heart of Health Policy and Systems [Volume 13, Issue 1, 2024, Pages 1-4]
  • Resilience We Need a Combination of Approaches to Evaluate Health System Resilience; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic [Volume 13, Issue 1, 2024, Pages 1-3]
  • Resilience Factors of Power and Equity: Enhancing Our Health System Resilience Research Frameworks; Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Resilience Learning From Countries on Measuring and Defining Community-Based Resilience in Health Systems: Voices From Nepal, Sierra Leone, Liberia, and Ethiopia [Volume 13, Issue 1, 2024, Pages 1-12]
  • Resilience Learning Health Systems Are Resilient Health Systems Comment on “Re-evaluating Our Knowledge of Health System Resilience During COVID-19: Lessons From the First Two Years of the Pandemic” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Resilience Capacity How Is Health System Resilience Being Assessed? A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Resilience Strategy How Is Health System Resilience Being Assessed? A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Resistance Decentralisation of the Health System Derailed by Organisational Inertia in Machinga, Malawi [Volume 13, Issue 1, 2024, Pages 1-11]
  • Resource Allocation  Institutional Priority-Setting for Novel Drugs and Therapeutics: A Qualitative Systematic Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Responsible Innovation To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practiceand Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue [Volume 13, Issue 1, 2024, Pages 1-14]
  • Retiree Contributions A Need for Honoring Healthcare Retirees: Proposed Recommendations [Volume 13, Issue 1, 2024, Pages 1-2]
  • Risk Factors Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea [Volume 13, Issue 1, 2024, Pages 1-9]
  • Rural Areas Exploring the County Level Mortality Pattern Variations in Rural Areas of Iran (2006-2016) [Volume 13, Issue 1, 2024, Pages 1-8]
  • Rural China  Subgroups of High-Cost Patients and Their Preventable Inpatient Cost in Rural China [Volume 13, Issue 1, 2024, Pages 1-11]
  • Rural Proofing In-Between Policy Vision and Practical Realities of Primary Healthcare: A Case Study in Rural Northern Sweden [Volume 13, Issue 1, 2024, Pages 1-11]

S

  • SADC Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment [Volume 13, Issue 1, 2024, Pages 1-11]
  • SF-6Dv2 Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada [Volume 13, Issue 1, 2024, Pages 1-12]
  • Scale Identifying Positive Practices to Institutionalize Social Innovation in the Malawian Health System [Volume 13, Issue 1, 2024, Pages 1-11]
  • Scientific Impact All Hands on Deck. Transforming the Health System Requires Innovation, Through Individual- and Diffusion Efforts; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Scientific Publication Why Are African Researchers Left Behind in Global Scientific Publications? – A Viewpoint [Volume 13, Issue 1, 2024, Pages 1-4]
  • Scoping Review How Is Health System Resilience Being Assessed? A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Self-Perceived Age Negative Emotions Are Associated With Older Self-perceived Age: A Cross-section Study From the UK Biobank [Volume 13, Issue 1, 2024, Pages 1-8]
  • Service Delivery  Public Heterogeneous Preferences for Low-Dose Computed Tomography Lung Cancer Screening Service Delivery in Western China: A Discrete Choice Experiment [Volume 13, Issue 1, 2024, Pages 1-11]
  • Settler Colonialism The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point [Volume 13, Issue 1, 2024, Pages 1-3]
  • Settler Colonialism Centering Local Knowledge to Address the Imbrication of Settler Colonialism and Global Health; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Settler Colonialism Are Burned Babies and Mass Graves a Global Health Crisis? What Does Decolonization Got to Do With It?; Comment on “The Rhetoric of Decolonizing Global Health Fails to Address the Reality of Settler Colonialism: Gaza as a Case in Point?” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Shock How Is Health System Resilience Being Assessed? A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Simulation Helping Healthcare to Help Itself: A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Social Cohesion Building Trust and Trustworthiness in Public Institutions: Essential Elements in Placing Trust at the Heart of Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Social Comparison Frontrunning, Free-Riding and Over-Aspiring: A Case Study Exploring How Configurations of Involvement, Social Comparison and Organizational Goal Attainment Affect Perceived Network Goal Attainment [Volume 13, Issue 1, 2024, Pages 1-13]
  • Social Determinants of Health Intersectoral Partnerships Between Local Governments and Health Organisations in High-Income Contexts: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Social Movements The Role of Social Movements in Reducing Harmful Corporate Practices; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Social Science A Multifaceted Approach to Health Crisis in the Philippines; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Social Science Health and Social Care Inequalities During the First Wave of COVID-19 in Italy; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Social Sciences Essential Factors on Effective Response at the Onset of the COVID-19 Pandemic; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • South Korea  The Effect of Integrated Care After Discharge From Hospitals on Outcomes Among Korean Older Adults [Volume 13, Issue 1, 2024, Pages 1-8]
  • Spatial Autocorrelation Exploring the County Level Mortality Pattern Variations in Rural Areas of Iran (2006-2016) [Volume 13, Issue 1, 2024, Pages 1-8]
  • Spatial Clustering Exploring the County Level Mortality Pattern Variations in Rural Areas of Iran (2006-2016) [Volume 13, Issue 1, 2024, Pages 1-8]
  • Stakeholder Consultation Standing on the Shoulder of Power, Representation and Relational Trust; A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Stakeholder Involvement Moving Towards Effective and Efficient Implementation of Evidence-Informed Deliberative Processes for Health Benefit Package Design: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Stewardship The Meso-Level in Quality Improvement: Perspectives From a Maternal-Neonatal Health Partnership in South Africa [Volume 13, Issue 1, 2024, Pages 1-9]
  • Strategy Organizational Culture Relation With Innovation; Comment on “Employee-Driven Innovation in Health Organizations: Insights From a Scoping Review” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Supermarkets A Systems Innovation Perspective on Implementation and Sustainment Barriers for Healthy Food Store Interventions: A Reflexive Monitoring in Action Study in Dutch Supermarkets [Volume 13, Issue 1, 2024, Pages 1-12]
  • Supervision Empowerment of Lay Mental Health Workers and Junior Psychologists Online in a Task-Shared, Rural Setting in Kerala, India [Volume 13, Issue 1, 2024, Pages 1-11]
  • Surgery Evidence-Informed Surgical Systems Strengthening with Meaningful Stakeholder Involvement in Low-Resource Settings: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • Surveillance How Could We Establish Monitoring and Surveillance of Health-Harming Corporations and Can Governments Be Trusted to Do It?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Sustainability To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practiceand Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue [Volume 13, Issue 1, 2024, Pages 1-14]
  • Sustainability Life After the HSIF: Lessons From Diffusion of Innovation for Sustaining the Impact of Embeddedness; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Sustainable Development Goals Examining the Contextual Factors Influencing Intersectoral Action for the SDGs: Insights From Canadian Federal Policy Leaders [Volume 13, Issue 1, 2024, Pages 1-10]
  • Sustainment  A Systems Innovation Perspective on Implementation and Sustainment Barriers for Healthy Food Store Interventions: A Reflexive Monitoring in Action Study in Dutch Supermarkets [Volume 13, Issue 1, 2024, Pages 1-12]
  • Sweden In-Between Policy Vision and Practical Realities of Primary Healthcare: A Case Study in Rural Northern Sweden [Volume 13, Issue 1, 2024, Pages 1-11]
  • System Dynamics Helping Healthcare to Help Itself: A Response to the Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]
  • System Mapping How Is Health System Resilience Being Assessed? A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-13]
  • Systematic Review Value-Based Integrated Care: A Systematic Literature Review [Volume 13, Issue 1, 2024, Pages 1-17]
  • Systematic Review Spatial Distribution and Birth Prevalence of Congenital Heart Disease in Iran: A Systematic Review and Hierarchical Bayesian Meta-analysis [Volume 13, Issue 1, 2024, Pages 1-11]
  • Systems Mapping Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-17]
  • Systems Thinking Interventions Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-20]

T

  • TRIPS Waiver Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Teleconsultations The Adaptation of Digital Health Solutions During the COVID-19 Pandemic in Hungary: A Scoping Review [Volume 13, Issue 1, 2024, Pages 1-9]
  • Territorial Divide Health and Social Care Inequalities During the First Wave of COVID-19 in Italy; Comment on “Experiences and Implications of the First Wave of the COVID-19 Emergency in Italy: A Social Science Perspective” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Territorial Structuring How Primary Healthcare Sector is Organized at the Territorial Level in France? A Typology of Territorial Structuring [Volume 13, Issue 1, 2024, Pages 1-13]
  • Thailand Health Insurance Schemes and Their Influences on Healthcare Variation in Asian Countries: A Realist Review and Theory’s Testing in Thailand [Volume 13, Issue 1, 2024, Pages 1-18]
  • Thailand  Scoping Review of International Experience of a Dedicated Fund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand [Volume 13, Issue 1, 2024, Pages 1-15]
  • The Consistency Evaluation Policy Chinese Physicians’ Preference for Prescribing Brand-Name vs. Generic: A Discrete Choice Experimen [Volume 13, Issue 1, 2024, Pages 1-9]
  • The Netherlands Next Steps for Medical Specialist Enterprises in the Netherlands: Building Strong Clinical Governance and Leadership; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • The Netherlands Construct Clarity in Physician-Hospital Alignment: The Need for Precision in Definition, Measurement, and Management; Comment on “Alignment in the Hospital-Physician Relationship: A Qualitative Multiple Case Study of Medical Specialist Enterprises in the Netherlands” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Thematic Analysis Retailer Responses to Public Consultations on the Adoption of Takeaway Management Zones Around Schools: A Longitudinal Qualitative Analysis [Volume 13, Issue 1, 2024, Pages 1-12]
  • Theories Policy Horses Still Running Around Healthcare Courses: A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-2]
  • Tobacco Control Tobacco Industry Engagement in the House of Commons Science and Technology Select Committee E-Cigarettes Inquiry [Volume 13, Issue 1, 2024, Pages 1-10]
  • Tobacco Industry Tobacco Industry Engagement in the House of Commons Science and Technology Select Committee E-Cigarettes Inquiry [Volume 13, Issue 1, 2024, Pages 1-10]
  • Training Continuing Education in Digital Skills for Healthcare Professionals — Mapping of the Current Situation in EU Member States [Volume 13, Issue 1, 2024, Pages 1-7]
  • Training Programs Training an Embedded Workforce to Realize Health System Impacts and the Promise of Learning Health Systems; Comment on “Early Career Outcomes of Embedded Research Fellows: An Analysis of the Health System Impact Fellowship Program” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Transdisciplinarity Narrative Preparedness: Policy-Makers Must Engage With People’s Values and Experiences to Ensure Effective Implementation of Interventions in Health Emergencies; Comment on “Health Preparedness and Narrative Rationality: A Call for Narrative Preparedness” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Transferability Assessing Global Evidence on Cost-Effectiveness to Inform Development of Pakistan’s Essential Package of Health Services [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-9]
  • Transferability Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions [Volume 13, Issue 1, 2024, Pages 1-9]
  • Transparency Lobbying in the Sunlight: A Scoping Review of Frameworks to Measure the Accessibility of Lobbying Disclosures [Volume 13, Issue 1, 2024, Pages 1-14]
  • Transparency Political Considerations When Monitoring the Commercial Determinants of Health; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Trends Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021 [Volume 13, Issue 1, 2024, Pages 1-9]
  • Trust Placing Trust at the Heart of Health Policy and Systems [Volume 13, Issue 1, 2024, Pages 1-4]
  • Trust Narrative Preparedness: Policy-Makers Must Engage With People’s Values and Experiences to Ensure Effective Implementation of Interventions in Health Emergencies; Comment on “Health Preparedness and Narrative Rationality: A Call for Narrative Preparedness” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Trust Bringing Trust Building to Life Within Health Policy-Making; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Trust Building Trust and Trustworthiness in Public Institutions: Essential Elements in Placing Trust at the Heart of Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Trustworthiness Bringing Trust Building to Life Within Health Policy-Making; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Trustworthiness Building Trust and Trustworthiness in Public Institutions: Essential Elements in Placing Trust at the Heart of Health Policy and Systems; Comment on “Placing Trust at the Heart of Health Policy and Systems” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Tuberculosis Effect of Cost-Exemption Policy on Treatment Interruption in Patients With Newly Diagnosed Pulmonary Tuberculosis in South Korea [Volume 13, Issue 1, 2024, Pages 1-9]

U

  • UHC Costing Interventions for Developing an Essential Package of Health Services: Application of a Rapid Method and Results From Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-17]
  • UK The Perils of Partnership: Interactions Between Public Health England, Drinkaware, and the Portman Group Surrounding the Drink Free Days Campaign [Volume 13, Issue 1, 2024, Pages 1-9]
  • UK Experiences of Research Coproduction in Uganda; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • UK Biobank Negative Emotions Are Associated With Older Self-perceived Age: A Cross-section Study From the UK Biobank [Volume 13, Issue 1, 2024, Pages 1-8]
  • Uganda Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda [Volume 13, Issue 1, 2024, Pages 1-14]
  • Uganda Experiences of Research Coproduction in Uganda; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Unhealthy Commodities Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-20]
  • Unhealthy Commodities Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy [Volume 13, Issue 1, 2024, Pages 1-17]
  • Unhealthy Commodities Industries Governing Political Realities in NCD Agenda Setting in LMICs: A Case of the Carrot and the Stick?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries: A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Unhealthy Commodity Industries Is a Government-Led Approach to Surveil Unhealthy Commodity Industries Feasible?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Unhealthy Commodity Industry How Could We Establish Monitoring and Surveillance of Health-Harming Corporations and Can Governments Be Trusted to Do It?; Comment on “National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries – A Scoping Review and Framework Synthesis” [Volume 13, Issue 1, 2024, Pages 1-5]
  • United Kingdom Tobacco Industry Engagement in the House of Commons Science and Technology Select Committee E-Cigarettes Inquiry [Volume 13, Issue 1, 2024, Pages 1-10]
  • Universal Health Coverage Addressing the UHC Challenge Using the Disease Control Priorities 3 Approach: Lessons Learned and an Overview of the Pakistan Experience [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-10]
  • Universal Health Coverage The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-8]
  • Universal Health Coverage Pakistan’s Progress on Universal Health Coverage: Lessons Learned in Priority Setting and Challenges Ahead in Reinforcing Primary Healthcare [Volume 13, Special Issue on Pakistan’s Progress on UHC, 2024, Pages 1-5]
  • Universal Health Coverage Technical Efficiency of Prevention Services for Functional Dependency in Japan’s Public Long-term Care Insurance System: An Ecological Study [Volume 13, Issue 1, 2024, Pages 1-8]
  • Urbanisation Entry of Migrant Workers to Malaysia: Consideration to Implement Mass Drug Administration Against Intestinal Parasitic Infections [Volume 13, Issue 1, 2024, Pages 1-5]
  • Utilization Discrepancies Among Hospitals and Regions in the Provision of Low-Value Care [Volume 13, Issue 1, 2024, Pages 1-10]

V

  • Vaccine Agreement Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Valuation Valuing SF-6Dv2 Using a Discrete Choice Experiment in a General Population in Quebec, Canada [Volume 13, Issue 1, 2024, Pages 1-12]
  • Value-Based Healthcare Value-Based Integrated Care: A Systematic Literature Review [Volume 13, Issue 1, 2024, Pages 1-17]
  • Values A Co-production Values and Principles Compass to Guide Along the Underused Pathway; Comment on “Research Coproduction: An Underused Pathway to Impact” [Volume 13, Issue 1, 2024, Pages 1-5]
  • Voluntary Licensing Agreements Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access; Comment on “More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap” [Volume 13, Issue 1, 2024, Pages 1-4]
  • Vulnerable Populations Equity Lens on Canada’s COVID-19 Response: Review of the Literature [Volume 13, Issue 1, 2024, Pages 1-9]

W

  • Well-Being Economics Can a Well-Being Economy Save Us? [Volume 13, Issue 1, 2024, Pages 1-6]
  • Well-Being Economy Well-Being Economics – From Slogan to Discipline?; Comment on “Can a Well-Being Economy Save Us?” [Volume 13, Issue 1, 2024, Pages 1-3]
  • Wet Age-Related Macular Degeneration Changing Reimbursement Criteria on Anti-VEGF Treatment Patterns Among Wet Age-Related Macular Degeneration and Diabetic Macular Edema Patients: An Interrupted Time Series Analysis [Volume 13, Issue 1, 2024, Pages 1-10]
  • World Management Survey How Does Management Matter for Hospital Performance? Evidence From the Global Hospital Management Survey in China [Volume 13, Issue 1, 2024, Pages 1-9]

Y

  • Youth Participation Praxis, Power, and Processes: Youth Participation in Health Policy – A Response to Recent Commentaries [Volume 13, Issue 1, 2024, Pages 1-3]

Z

  • ZaZiBoNa Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment [Volume 13, Issue 1, 2024, Pages 1-11]